	ID	Description	GeneRatio	BgRatio	pvalue	geneID	Count
WP2272	WP2272	Pathogenic Escherichia coli infection	8/115	55/8701	5.28991252069333e-07	60/10094/3688/4690/6093/7277/7454/10971	8
WP524	WP524	G13 signaling pathway	7/115	39/8701	6.35892077343361e-07	801/23191/10672/10788/5305/6093/7454	7
WP51	WP51	Regulation of actin cytoskeleton	12/115	151/8701	6.39091054707987e-07	60/55845/26999/10672/4478/5305/8396/79837/6093/6548/7114/7454	12
WP306	WP306	Focal adhesion	13/115	199/8701	1.99726919293776e-06	60/2316/2317/3611/3674/3688/3690/103910/29780/5908/6093/6714/7094	13
WP2572	WP2572	Primary focal segmental glomerulosclerosis (FSGS)	8/115	72/8701	4.31505082419743e-06	3611/3688/3690/3987/4627/4690/7094/10971	8
WP3888	WP3888	VEGFA-VEGFR2 signaling	18/115	432/8701	1.29413360324923e-05	226/832/1192/1465/2317/2597/3688/3690/4629/4627/4690/5908/6093/83442/6648/6714/6774/7114	18
WP185	WP185	Integrin-mediated cell adhesion	8/115	102/8701	5.69059645862116e-05	3611/3674/3688/3690/5908/6093/6714/7094	8
WP2032	WP2032	Thyroid stimulating hormone (TSH) signaling pathway	6/115	66/8701	0.000222818800260887	10672/3716/103910/5908/6714/6774	6
WP4534	WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	5/115	47/8701	0.000364124709725861	60/3688/3690/6714/10971	5
WP2037	WP2037	Prolactin signaling pathway	6/115	76/8701	0.000481719674758017	2316/3688/3716/6714/6774/6777	6
WP286	WP286	IL-3 signaling pathway	5/115	50/8701	0.000487360166334267	3716/6714/6774/6777/10971	5
WP313	WP313	Hepatocyte growth factor receptor signaling	4/115	34/8701	0.000988949260781436	3688/5908/6714/6774	4
WP4549	WP4549	Fragile X syndrome	7/115	122/8701	0.00112462641601484	23191/26999/1785/4204/57521/6455/6714	7
WP1946	WP1946	Cori cycle	3/115	17/8701	0.00133612348354111	226/2597/6888	3
WP22	WP22	IL-9 signaling pathway	3/115	17/8701	0.00133612348354111	3716/6774/6777	3
WP2324	WP2324	AGE/RAGE pathway	5/115	66/8701	0.00173861187474184	4478/6093/6714/6774/6777	5
WP127	WP127	IL-5 signaling pathway	4/115	40/8701	0.00183376925804101	3716/6199/6774/6777	4
WP500	WP500	Glycogen synthesis and degradation	4/115	40/8701	0.00183376925804101	801/5520/5834/5836	4
WP3303	WP3303	RAC1/PAK1/p38/MMP2 pathway	5/115	68/8701	0.00198600750666009	3688/4690/6714/6774/6777	5
WP49	WP49	IL-2 signaling pathway	4/115	42/8701	0.00220086973754588	3716/6199/6774/6777	4
WP5376	WP5376	17p13.3 (YWHAE) copy number variation	3/115	21/8701	0.00251467019979692	84516/5048/10971	3
WP2038	WP2038	Microtubule cytoskeleton regulation	4/115	46/8701	0.00308142834694685	1808/6093/6714/6774	4
WP2034	WP2034	Leptin signaling pathway	5/115	76/8701	0.00323800122455747	3716/6093/6714/6774/6777	5
WP2203	WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	4/115	47/8701	0.00333420077831624	3716/6714/6774/6777	4
WP1528	WP1528	Physiological and pathological hypertrophy of the heart	3/115	24/8701	0.00371821731754448	801/5532/6774	3
WP205	WP205	IL-7 signaling pathway	3/115	25/8701	0.00418493508992331	3716/6774/6777	3
WP581	WP581	EPO receptor signaling	3/115	26/8701	0.00468568816720952	6714/6774/6777	3
WP4018	WP4018	Clear cell renal cell carcinoma pathways	5/115	86/8701	0.00550057886301007	47/226/2597/57521/6774	5
WP4298	WP4298	Acute viral myocarditis	5/115	86/8701	0.00550057886301007	60/3611/3716/6714/6774	5
WP395	WP395	IL-4 signaling pathway	4/115	54/8701	0.00550851312169698	2316/3716/6774/6777	4
WP437	WP437	EGF/EGFR signaling pathway	7/115	163/8701	0.00574547668367458	3716/4690/5037/6093/6714/6774/6777	7
WP2643	WP2643	Nanoparticle-mediated activation of receptor signaling	3/115	28/8701	0.00579201652962302	3688/6714/7094	3
WP3929	WP3929	Chemokine signaling pathway	7/115	166/8701	0.00633595567882106	5196/5473/5908/6093/6774/6777/7454	7
WP3972	WP3972	PDGFR-beta pathway	3/115	29/8701	0.00639883890878884	3716/6774/6777	3
WP4217	WP4217	Ebola virus infection in host	6/115	129/8701	0.00713082073992566	60/2316/2317/3688/3690/7251	6
WP4352	WP4352	Ciliary landscape	8/115	215/8701	0.00751663373923515	26286/801/23549/140735/10788/10982/5048/4218	8
WP5399	WP5399	NPHP1 deletion syndrome	2/115	11/8701	0.0088108697396977	2316/2317	2
WP5358	WP5358	JAK-STAT signaling in the regulation of Beta-cells	3/115	34/8701	0.00999070649689324	57521/6774/6777	3
WP4495	WP4495	IL-10 anti-inflammatory signaling pathway 	2/115	12/8701	0.0104823178530175	3716/6774	2
WP4629	WP4629	Aerobic glycolysis	2/115	12/8701	0.0104823178530175	226/2597	2
WP2374	WP2374	Oncostatin M signaling pathway	4/115	65/8701	0.0105579784867744	3716/6714/6774/6777	4
WP3680	WP3680	Physico-chemical features and toxicity-associated pathways	4/115	66/8701	0.0111269698810991	10096/4690/6714/7114	4
WP3850	WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	3/115	36/8701	0.0116957919256048	3611/3688/57521	3
WP2380	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	6/115	144/8701	0.0119214667720194	23191/1808/4690/6714/6774/6777	6
WP2526	WP2526	PDGF pathway	3/115	40/8701	0.0155802052974089	3716/6714/6774	3
WP3584	WP3584	MECP2 and associated Rett syndrome	4/115	73/8701	0.0156664112243392	1465/4155/4204/11168	4
WP5063	WP5063	FOXP3 in COVID-19	2/115	15/8701	0.0162516697298101	6774/6777	2
WP2636	WP2636	Common pathways underlying drug addiction	3/115	41/8701	0.0166514163679115	60/801/5908	3
WP2118	WP2118	Arrhythmogenic right ventricular cardiomyopathy	4/115	75/8701	0.0171484667274868	60/3674/3688/3690	4
WP4290	WP4290	Metabolic reprogramming in colon cancer	3/115	42/8701	0.0177629968779396	47/2597/6888	3
WP4659	WP4659	Gastrin signaling pathway	5/115	115/8701	0.0179559944379267	3688/6093/6548/6714/6774	5
WP12	WP12	Osteoclast signaling	2/115	16/8701	0.0184146244166386	3690/6548	2
WP4962	WP4962	Airway smooth muscle cell contraction	2/115	16/8701	0.0184146244166386	801/6093	2
WP4538	WP4538	Regulatory circuits of the STAT3 signaling pathway	4/115	78/8701	0.0195312479239116	3716/57521/6714/6774	4
WP2332	WP2332	Interleukin-11 signaling pathway	3/115	44/8701	0.0201076907633676	3716/6714/6774	3
WP4823	WP4823	Genes controlling nephrogenesis	3/115	44/8701	0.0201076907633676	3611/3688/4690	3
WP4337	WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2/115	17/8701	0.020691757874385	3716/6774	2
WP4806	WP4806	EGFR tyrosine kinase inhibitor resistance	4/115	84/8701	0.0248864552019837	3716/6199/6714/6774	4
WP4971	WP4971	Phosphoinositides metabolism	3/115	49/8701	0.0266805753600203	5305/8396/79837	3
WP5300	WP5300	TROP2 regulatory signaling	3/115	49/8701	0.0266805753600203	3688/6714/7094	3
WP4263	WP4263	Pancreatic adenocarcinoma pathway	4/115	89/8701	0.0299650001166118	3716/5037/6199/6774	4
WP138	WP138	Androgen receptor signaling pathway	4/115	91/8701	0.0321559230494453	2316/6093/6714/6774	4
WP673	WP673	ErbB signaling pathway	4/115	92/8701	0.0332858256955001	4690/6199/6714/6777	4
WP4630	WP4630	Measles virus infection	5/115	136/8701	0.0339421586520717	3716/4478/4940/6774/6777	5
WP585	WP585	Interferon type I signaling pathways	3/115	54/8701	0.0342663985597957	3716/57521/6774	3
WP2806	WP2806	Complement system	4/115	97/8701	0.0392814709619083	2162/3674/3690/7454	4
WP5265	WP5265	Neurogenesis regulation in the olfactory epithelium	3/115	57/8701	0.0392984113658712	4204/5048/6774	3
WP304	WP304	Kit receptor signaling pathway	3/115	59/8701	0.0428503095397515	6714/6774/6777	3
WP4205	WP4205	MET in type 1 papillary renal cell carcinoma	3/115	59/8701	0.0428503095397515	5908/6714/6774	3
WP5224	WP5224	2q37 copy number variation syndrome	5/115	145/8701	0.0428522390561316	801/9267/3611/3690/4134	5
WP183	WP183	Proteasome degradation	3/115	62/8701	0.0484693427117465	5699/5711/5721	3
WP1544	WP1544	MicroRNAs in cardiomyocyte hypertrophy	4/115	104/8701	0.048647857064544	801/5532/6093/6774	4
WP2035	WP2035	Follicle stimulating hormone (FSH) signaling pathway	2/115	27/8701	0.0490401937916761	6199/6714	2
WP4666	WP4666	Hepatitis B infection	5/115	151/8701	0.0495082294529058	3716/6714/6774/6777/10971	5
WP474	WP474	Endochondral ossification	3/115	63/8701	0.0504189431394783	801/871/6777	3
WP4808	WP4808	Endochondral ossification with skeletal dysplasias	3/115	63/8701	0.0504189431394783	801/871/6777	3
WP2583	WP2583	T cell receptor and co-stimulatory signaling	2/115	28/8701	0.0523669766579879	801/1859	2
WP5039	WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	3/115	66/8701	0.0564933891816599	3716/5196/5473	3
WP2263	WP2263	Androgen receptor network in prostate cancer	4/115	110/8701	0.057576472853716	3716/5908/57521/6774	4
WP706	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	5/115	160/8701	0.0605779783664484	226/2597/4204/6711/10971	5
WP4868	WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2/115	31/8701	0.0628065280024022	3716/4940	2
WP2112	WP2112	IL-17 signaling pathway	2/115	32/8701	0.0664309277516296	3716/6774	2
WP5312	WP5312	Metabolic pathways of fibroblasts	2/115	32/8701	0.0664309277516296	5033/871	2
WP4786	WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	2/115	33/8701	0.0701234757485354	5033/871	2
WP4874	WP4874	CAMKK2 pathway	2/115	33/8701	0.0701234757485354	801/57521	2
WP4880	WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2/115	33/8701	0.0701234757485354	3716/4940	2
WP4542	WP4542	Leukocyte-intrinsic Hippo pathway functions	2/115	35/8701	0.0777034743203784	83706/10971	2
WP619	WP619	Type II interferon signaling	2/115	37/8701	0.0855279390262644	2633/3716	2
WP383	WP383	Striated muscle contraction pathway	2/115	38/8701	0.0895262524106777	7168/7171	2
WP4829	WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/115	38/8701	0.0895262524106777	6093/6774	2
WP5413	WP5413	IL-24 Signaling pathway	7/115	291/8701	0.0903520467600462	60/3611/3674/3716/6648/6714/6774	7
WP5093	WP5093	Opioid receptor pathways	2/115	41/8701	0.101839798817854	4155/6548	2
WP3932	WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	7/115	302/8701	0.104689301353423	3674/3688/3690/3716/4218/6199/57521	7
WP364	WP364	IL6 signaling pathway	2/115	43/8701	0.110293813507463	3716/6774	2
WP5083	WP5083	Neuroinflammation and glutamatergic signaling	4/115	140/8701	0.11408871363226	801/2752/3716/6774	4
WP314	WP314	Fas ligand pathway and stress induction of heat shock proteins	2/115	44/8701	0.114588390780991	60/6709	2
WP4577	WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	2/115	44/8701	0.114588390780991	4204/57521	2
WP5085	WP5085	Vasopressin-regulated water reabsorption	2/115	44/8701	0.114588390780991	84516/140735	2
WP534	WP534	Glycolysis and gluconeogenesis	2/115	45/8701	0.118925481082699	226/2597	2
WP3925	WP3925	Amino acid metabolism	3/115	91/8701	0.119017188964905	47/128/2752	3
WP35	WP35	G protein signaling pathways	3/115	92/8701	0.121907010198705	801/10672/6548	3
WP4566	WP4566	Translation inhibitors in chronically activated PDGFRA cells	2/115	46/8701	0.123303236160988	6199/57521	2
WP2113	WP2113	Type III interferon signaling	1/115	10/8701	0.124639291627651	3716	1
WP2815	WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	1/115	10/8701	0.124639291627651	6774	1
WP5050	WP5050	TCA cycle in senescence	1/115	10/8701	0.124639291627651	4200	1
WP5347	WP5347	IL-26 signaling pathways	2/115	47/8701	0.12771984841703	3716/6774	2
WP4746	WP4746	Thyroid hormones production and peripheral downstream signaling effects	3/115	94/8701	0.127763537314181	3690/57521/6714	3
WP1455	WP1455	Serotonin transporter activity	1/115	11/8701	0.136222133816447	3690	1
WP5049	WP5049	Glycolysis in senescence	1/115	11/8701	0.136222133816447	2597	1
WP5233	WP5233	Arsenic metabolism and reactive oxygen species generation	1/115	11/8701	0.136222133816447	6648	1
WP5409	WP5409	PAFAH1B1 copy number variation	1/115	11/8701	0.136222133816447	5048	1
WP5199	WP5199	PtdIns(4,5)P2 in cytokinesis pathway	1/115	12/8701	0.147653026176758	4478	1
WP289	WP289	Myometrial relaxation and contraction pathways	4/115	156/8701	0.151423276369171	60/801/1265/10971	4
WP5381	WP5381	Smith-Magenis and Potocki-Lupski syndrome copy number variation	4/115	159/8701	0.158895267108456	4218/6093/57521/6774	4
WP1434	WP1434	Osteopontin signaling	1/115	13/8701	0.158933944808324	3690	1
WP2881	WP2881	Estrogen receptor pathway	1/115	13/8701	0.158933944808324	6774	1
WP3301	WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1/115	13/8701	0.158933944808324	3690	1
WP3892	WP3892	Development of pulmonary dendritic cells and macrophage subsets	1/115	13/8701	0.158933944808324	6774	1
WP4792	WP4792	Purine metabolism	1/115	13/8701	0.158933944808324	100	1
WP4947	WP4947	Nitric oxide metabolism in cystic fibrosis	1/115	13/8701	0.158933944808324	23564	1
WP5173	WP5173	Disorders of galactose metabolism 	1/115	13/8701	0.158933944808324	5836	1
WP4172	WP4172	PI3K-Akt signaling pathway	7/115	339/8701	0.161246165426436	3674/3688/3690/3716/5520/6199/57521	7
WP560	WP560	TGF-beta receptor signaling	2/115	55/8701	0.164247536460893	3716/6774	2
WP3646	WP3646	Hepatitis C and hepatocellular carcinoma	2/115	56/8701	0.168938874116088	3716/6774	2
WP322	WP322	Osteoblast signaling	1/115	14/8701	0.170066840336298	3690	1
WP5318	WP5318	Female steroid hormones in cardiomyocyte energy metabolism	1/115	14/8701	0.170066840336298	47	1
WP4321	WP4321	Thermogenesis	3/115	108/8701	0.171325414224241	60/6199/57521	3
WP1559	WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	1/115	15/8701	0.181053638236761	6774	1
WP4816	WP4816	TGF-beta receptor signaling in skeletal dysplasias	2/115	59/8701	0.183144459875639	3716/6774	2
WP5407	WP5407	15q11q13 copy number variation	2/115	59/8701	0.183144459875639	801/871	2
WP5055	WP5055	Burn wound healing	3/115	113/8701	0.187812582142402	1265/2162/871	3
WP5053	WP5053	Development of ureteric collection system	2/115	60/8701	0.187918932611894	3611/3688	2
WP2453	WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	1/115	16/8701	0.191896239158103	47	1
WP61	WP61	Notch signaling pathway	2/115	61/8701	0.192710833678129	6714/6774	2
WP3863	WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	2/115	62/8701	0.197518883377009	801/4690	2
WP5180	WP5180	DYRK1A involvement regarding cell proliferation in brain development	2/115	62/8701	0.197518883377009	1859/57521	2
WP5362	WP5362	TAR syndrome	2/115	63/8701	0.202341832237256	3688/6774	2
WP3678	WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	1/115	17/8701	0.202596519238336	6714	1
WP3935	WP3935	Leptin-insulin signaling overlap	1/115	17/8701	0.202596519238336	6774	1
WP4462	WP4462	Platelet-mediated interactions with vascular and circulating cells	1/115	17/8701	0.202596519238336	5196	1
WP4493	WP4493	Cells and molecules involved in local acute inflammatory response 	1/115	17/8701	0.202596519238336	3688	1
WP4872	WP4872	MAP3K1 role in promoting and blocking gonadal determination	1/115	17/8701	0.202596519238336	6093	1
WP2849	WP2849	Hematopoietic stem cell differentiation	2/115	64/8701	0.207178460450023	3674/3690	2
WP3624	WP3624	Lung fibrosis	2/115	64/8701	0.207178460450023	91039/4204	2
WP1992	WP1992	Genes targeted by miRNAs in adipocytes	1/115	18/8701	0.21315633041839	7114	1
WP2813	WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	1/115	18/8701	0.21315633041839	3688	1
WP4533	WP4533	Transcription co-factors SKI and SKIL protein partners	1/115	18/8701	0.21315633041839	4204	1
WP4560	WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	1/115	18/8701	0.21315633041839	3690	1
WP5223	WP5223	2q21.1 copy number variation syndrome	1/115	18/8701	0.21315633041839	6774	1
WP4541	WP4541	Hippo-Merlin signaling dysregulation	3/115	121/8701	0.2149897440702	3674/3688/3690	3
WP1403	WP1403	AMP-activated protein kinase signaling	2/115	67/8701	0.221758656477528	6199/57521	2
WP5087	WP5087	Pleural mesothelioma	8/115	440/8701	0.225739853947638	60/3688/3690/3716/92597/6199/57521/6714	8
WP382	WP382	MAPK signaling pathway	5/115	247/8701	0.228100908576201	2316/2317/5494/5532/5908	5
WP516	WP516	Hypertrophy model	1/115	20/8701	0.233861834708315	9948	1
WP5331	WP5331	Autophagy in pancreatic ductal adenocarcinoma	1/115	20/8701	0.233861834708315	6774	1
WP5130	WP5130	Th17 cell differentiation pathway	2/115	70/8701	0.236420786565025	3716/6774	2
WP2359	WP2359	Parkin-ubiquitin proteasomal system pathway	2/115	71/8701	0.241321393159924	5711/7277	2
WP4906	WP4906	3q29 copy number variation syndrome	2/115	71/8701	0.241321393159924	140735/6777	2
WP4300	WP4300	Extracellular vesicles in the crosstalk of cardiac cells	1/115	21/8701	0.244011113479027	6774	1
WP4255	WP4255	Non-small cell lung cancer	2/115	72/8701	0.246226923886925	6774/6777	2
WP357	WP357	Fatty acid biosynthesis	1/115	22/8701	0.254027095270491	47	1
WP4674	WP4674	Head and neck squamous cell carcinoma	2/115	74/8701	0.256048875436774	6199/57521	2
WP2509	WP2509	Nanoparticle triggered autophagic cell death	1/115	23/8701	0.263911515600471	51100	1
WP4197	WP4197	Immune response to tuberculosis	1/115	23/8701	0.263911515600471	3716	1
WP4224	WP4224	Purine metabolism and related disorders	1/115	23/8701	0.263911515600471	100	1
WP4357	WP4357	NRF2-ARE regulation	1/115	23/8701	0.263911515600471	6714	1
WP4585	WP4585	Cancer immunotherapy by PD-1 blockade	1/115	23/8701	0.263911515600471	6774	1
WP4942	WP4942	15q13.3 copy number variation syndrome	1/115	23/8701	0.263911515600471	871	1
WP5294	WP5294	Sildenafil treatment	1/115	23/8701	0.263911515600471	2597	1
WP4656	WP4656	Joubert syndrome	2/115	76/8701	0.265879119015917	2316/4218	2
WP4949	WP4949	16p11.2 proximal deletion syndrome	2/115	76/8701	0.265879119015917	226/4478	2
WP1539	WP1539	Angiogenesis	1/115	24/8701	0.273666087587789	6714	1
WP1981	WP1981	Thyroxine (thyroid hormone) production	1/115	25/8701	0.283292502238867	5908	1
WP3668	WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	1/115	25/8701	0.283292502238867	2316	1
WP4483	WP4483	Relationship between inflammation, COX-2 and EGFR	1/115	25/8701	0.283292502238867	6714	1
WP4754	WP4754	IL-18 signaling pathway	5/115	273/8701	0.293357826058881	3674/5763/5834/57521/7114	5
WP5353	WP5353	A network map of Macrophage-stimulating protein (MSP) signaling	2/115	82/8701	0.29534995743393	3688/6714	2
WP4532	WP4532	Intraflagellar transport proteins binding to dynein	1/115	27/8701	0.30216751468982	140735	1
WP4856	WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1/115	27/8701	0.30216751468982	1785	1
WP5231	WP5231	Hippocampal synaptogenesis and neurogenesis	1/115	27/8701	0.30216751468982	801	1
WP5200	WP5200	Dravet syndrome	1/115	28/8701	0.311419386468777	801	1
WP3965	WP3965	Lipid metabolism pathway	1/115	29/8701	0.320549649417709	47	1
WP4905	WP4905	1q21.1 copy number variation syndrome	1/115	29/8701	0.320549649417709	50848	1
WP4969	WP4969	RAS and bradykinin pathways in COVID-19	1/115	29/8701	0.320549649417709	6093	1
WP5115	WP5115	Network map of SARS-CoV-2 signaling pathway	4/115	218/8701	0.325618971861061	60/3716/5196/57521	4
WP2855	WP2855	Dopaminergic neurogenesis	1/115	30/8701	0.329559888153521	6774	1
WP4923	WP4923	Autophagy	1/115	30/8701	0.329559888153521	57521	1
WP5102	WP5102	Familial partial lipodystrophy	1/115	30/8701	0.329559888153521	6777	1
WP69	WP69	T-cell receptor signaling pathway	2/115	90/8701	0.334366903372057	4690/7454	2
WP4304	WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	1/115	31/8701	0.338451666825225	4155	1
WP4912	WP4912	SARS coronavirus and innate immunity	1/115	31/8701	0.338451666825225	3716	1
WP5355	WP5355	Metabolic Epileptic Disorders	2/115	91/8701	0.339206222796936	226/2597	2
WP231	WP231	TNF-alpha signaling pathway	2/115	92/8701	0.344035094188008	2752/5836	2
WP2839	WP2839	Hair follicle development: organogenesis - part 2 of 3	1/115	32/8701	0.347226529375986	3688	1
WP2876	WP2876	Pregnane X receptor pathway	1/115	32/8701	0.347226529375986	6714	1
WP3414	WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/115	32/8701	0.347226529375986	5532	1
WP3844	WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer	1/115	32/8701	0.347226529375986	57521	1
WP3995	WP3995	Prion disease pathway	1/115	32/8701	0.347226529375986	6774	1
WP4149	WP4149	White fat cell differentiation	1/115	32/8701	0.347226529375986	6777	1
WP727	WP727	Monoamine transport	1/115	32/8701	0.347226529375986	3690	1
WP2197	WP2197	Endothelin pathways	1/115	33/8701	0.355885999801844	801	1
WP244	WP244	Alpha 6 beta 4 signaling pathway	1/115	33/8701	0.355885999801844	6714	1
WP408	WP408	Oxidative stress response	1/115	33/8701	0.355885999801844	6648	1
WP422	WP422	MAPK cascade	1/115	33/8701	0.355885999801844	4155	1
WP4875	WP4875	Disruption of postsynaptic signaling by CNV	1/115	33/8701	0.355885999801844	23191	1
WP4658	WP4658	Small cell lung cancer	2/115	96/8701	0.36323501036258	3674/3688	2
WP5221	WP5221	2q11.2 copy number variation syndrome	1/115	35/8701	0.37286476205676	6774	1
WP1471	WP1471	Target of rapamycin signaling	1/115	36/8701	0.381187004425036	57521	1
WP2064	WP2064	Neural crest differentiation	2/115	101/8701	0.386936566254363	3688/4155	2
WP5287	WP5287	17q12 copy number variation syndrome	2/115	101/8701	0.386936566254363	3927/8396	2
WP4558	WP4558	Overview of interferons-mediated signaling pathway	1/115	37/8701	0.389399756241668	3716	1
WP722	WP722	Serotonin HTR1 group and FOS pathway	1/115	37/8701	0.389399756241668	6774	1
WP399	WP399	Wnt signaling pathway and pluripotency	2/115	102/8701	0.391632407044749	5048/5520	2
WP5323	WP5323	Fatty Acids and Lipoproteins Transport in Hepatocytes	6/115	382/8701	0.392778231627363	47/51606/1785/1808/23048/6455	6
WP2447	WP2447	Amyotrophic lateral sclerosis (ALS)	1/115	38/8701	0.397504445534398	5532	1
WP3591	WP3591	Sleep regulation	1/115	38/8701	0.397504445534398	100	1
WP3298	WP3298	Melatonin metabolism and effects	1/115	39/8701	0.40550248186864	801	1
WP4932	WP4932	7q11.23 copy number variation syndrome	2/115	106/8701	0.410253555487513	2597/7251	2
WP2828	WP2828	Bladder cancer	1/115	40/8701	0.413395256584076	6714	1
WP4564	WP4564	Neural crest cell migration during development	1/115	40/8701	0.413395256584076	6774	1
WP5090	WP5090	Complement system in neuronal development and plasticity	2/115	107/8701	0.414866375616971	3690/4155	2
WP405	WP405	Eukaryotic transcription initiation	1/115	42/8701	0.428870496787095	3611	1
WP4148	WP4148	Splicing factor NOVA regulated synaptic proteins	1/115	42/8701	0.428870496787095	4134	1
WP5220	WP5220	Metabolic reprogramming in pancreatic cancer	1/115	42/8701	0.428870496787095	47	1
WP5380	WP5380	5q35 copy number variation	2/115	111/8701	0.43313724938785	79184/6714	2
WP4136	WP4136	Fibrin complement receptor 3 signaling pathway	1/115	43/8701	0.4364556559128	6714	1
WP4565	WP4565	Neural crest cell migration in cancer	1/115	43/8701	0.4364556559128	6774	1
WP5198	WP5198	Inflammatory bowel disease signaling	1/115	43/8701	0.4364556559128	6774	1
WP4756	WP4756	Renin-angiotensin-aldosterone system (RAAS)	1/115	44/8701	0.443940941148424	801	1
WP2873	WP2873	Aryl hydrocarbon receptor pathway	1/115	45/8701	0.451327656149918	6714	1
WP4758	WP4758	Nephrotic syndrome	1/115	45/8701	0.451327656149918	4627	1
WP5322	WP5322	CKAP4 signaling pathway map	2/115	116/8701	0.45554667134816	3688/6714	2
WP2586	WP2586	Aryl hydrocarbon receptor pathway	1/115	46/8701	0.458617087705227	6714	1
WP3931	WP3931	Embryonic stem cell pluripotency pathways	2/115	117/8701	0.459968536160783	3716/6774	2
WP5124	WP5124	Alzheimer's disease	4/115	263/8701	0.460417730934912	801/2597/5532/7277	4
WP4008	WP4008	NO/cGMP/PKG mediated neuroprotection	1/115	47/8701	0.465810505950623	801	1
WP1541	WP1541	Energy metabolism	1/115	48/8701	0.472909164584281	5532	1
WP410	WP410	Exercise-induced circadian regulation	1/115	48/8701	0.472909164584281	5813	1
WP4312	WP4312	Rett syndrome causing genes	1/115	48/8701	0.472909164584281	4204	1
WP4559	WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	1/115	48/8701	0.472909164584281	6774	1
WP1971	WP1971	Integrated cancer pathway	1/115	49/8701	0.479914301077151	3716	1
WP2637	WP2637	Interleukin-1 (IL-1) structural pathway	1/115	49/8701	0.479914301077151	4155	1
WP2029	WP2029	Cell differentiation - index	1/115	50/8701	0.486827136881142	6774	1
WP5373	WP5373	Role of hypoxia, angiogenesis, and FGF pathway in OA chondrocyte hypertrophy	1/115	50/8701	0.486827136881142	6774	1
WP1533	WP1533	Vitamin B12 metabolism	1/115	51/8701	0.493648877634658	6648	1
WP2267	WP2267	Synaptic vesicle pathway	1/115	51/8701	0.493648877634658	1785	1
WP4539	WP4539	Synaptic signaling pathways associated with autism spectrum disorder	1/115	51/8701	0.493648877634658	57521	1
WP4747	WP4747	Netrin-UNC5B signaling pathway	1/115	52/8701	0.500380713365527	6714	1
WP5095	WP5095	Overview of proinflammatory and profibrotic mediators	2/115	129/8701	0.511365280953454	5196/5473	2
WP5144	WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	1/115	54/8701	0.513579353017254	6714	1
WP236	WP236	Adipogenesis	2/115	131/8701	0.519619874928102	6774/6777	2
WP2018	WP2018	RANKL/RANK signaling pathway	1/115	55/8701	0.520048460731261	6714	1
WP2795	WP2795	Cardiac hypertrophic response	1/115	55/8701	0.520048460731261	801	1
WP3915	WP3915	Angiopoietin-like protein 8 regulatory pathway	2/115	132/8701	0.52371269275464	6199/57521	2
WP5348	WP5348	11p11.2 copy number variation syndrome 	1/115	56/8701	0.526432271396991	3688	1
WP4879	WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	1/115	57/8701	0.532731899944052	60	1
WP4917	WP4917	Proximal tubule transport	1/115	57/8701	0.532731899944052	51606	1
WP2023	WP2023	Cell differentiation - expanded index	1/115	59/8701	0.54508299835561	6774	1
WP5072	WP5072	Modulators of TCR signaling and T cell activation	1/115	61/8701	0.557110389803728	10672	1
WP2858	WP2858	Ectoderm differentiation	2/115	142/8701	0.56335249621859	4204/54521	2
WP4155	WP4155	Endometrial cancer	1/115	63/8701	0.568822485762596	3611	1
WP2525	WP2525	Trans-sulfuration, one-carbon metabolism and related pathways	1/115	68/8701	0.596776567884329	6648	1
WP3942	WP3942	PPAR signaling pathway	1/115	68/8701	0.596776567884329	3611	1
WP4685	WP4685	Melanoma	1/115	68/8701	0.596776567884329	801	1
WP536	WP536	Calcium regulation in cardiac cells	2/115	152/8701	0.600603770327784	801/10971	2
WP2882	WP2882	Nuclear receptors meta-pathway	4/115	314/8701	0.600683402907694	4259/5272/6714/6774	4
WP176	WP176	Folate metabolism	1/115	69/8701	0.602147898209048	6648	1
WP5158	WP5158	Urotensin-II-mediated signaling pathway	1/115	69/8701	0.602147898209048	6774	1
WP2880	WP2880	Glucocorticoid receptor pathway	1/115	70/8701	0.607448291131425	5272	1
WP1982	WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/115	71/8701	0.612678675388161	47	1
WP4341	WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	1/115	75/8701	0.632918281875329	3716	1
WP2059	WP2059	Alzheimer's disease and miRNA effects	4/115	328/8701	0.635261356710493	801/2597/5532/7277	4
WP4016	WP4016	DNA IR-damage and cellular response via ATR	1/115	81/8701	0.661327941627013	79184	1
WP2261	WP2261	Glioblastoma signaling pathways	1/115	83/8701	0.670304674056117	6714	1
WP4022	WP4022	Pyrimidine metabolism	1/115	84/8701	0.674704182350796	1633	1
WP15	WP15	Selenium micronutrient network	1/115	86/8701	0.683329350266555	6648	1
WP477	WP477	Cytoplasmic ribosomal proteins	1/115	88/8701	0.691727759481304	6199	1
WP5098	WP5098	T-cell activation SARS-CoV-2	1/115	88/8701	0.691727759481304	57521	1
WP2446	WP2446	Retinoblastoma gene in cancer	1/115	90/8701	0.699905320632056	1633	1
WP4223	WP4223	Ras signaling	2/115	184/8701	0.703726710352033	801/5908	2
WP702	WP702	Metapathway biotransformation Phase I and II	2/115	185/8701	0.706565138230613	8514/4259	2
WP1772	WP1772	Apoptosis modulation and signaling	1/115	92/8701	0.707867791618722	8682	1
WP2355	WP2355	Corticotropin-releasing hormone signaling pathway	1/115	92/8701	0.707867791618722	5908	1
WP2877	WP2877	Vitamin D receptor pathway	2/115	187/8701	0.712174759526603	4650/7168	2
WP4963	WP4963	p53 transcriptional gene network	1/115	96/8701	0.723169754389876	57521	1
WP23	WP23	B cell receptor signaling pathway	1/115	97/8701	0.726869403227199	4690	1
WP3594	WP3594	Circadian rhythm genes	2/115	201/8701	0.748993302673995	100/1859	2
WP5094	WP5094	Orexin receptor pathway	2/115	201/8701	0.748993302673995	7798/6774	2
WP5366	WP5366	NF1 copy number variation syndrome 	1/115	110/8701	0.770730290922792	51466	1
WP3998	WP3998	Prader-Willi and Angelman syndrome	1/115	111/8701	0.773799318573109	23191	1
WP710	WP710	DNA damage response (only ATM dependent)	1/115	111/8701	0.773799318573109	6648	1
WP5345	WP5345	1p36 copy number variation syndrome	1/115	112/8701	0.776827616403621	55229	1
WP428	WP428	Wnt signaling	1/115	115/8701	0.785673454687786	5532	1
WP179	WP179	Cell cycle	1/115	120/8701	0.799650583259716	10971	1
WP2431	WP2431	Spinal cord injury	1/115	121/8701	0.802335606325224	4155	1
WP2884	WP2884	NRF2 pathway	1/115	141/8701	0.849134101619824	4259	1
WP4673	WP4673	Male infertility	1/115	145/8701	0.857080827263398	6648	1
WP4262	WP4262	Breast cancer pathway	1/115	155/8701	0.87517815579096	6199	1
WP481	WP481	Insulin signaling	1/115	160/8701	0.883355392840077	6199	1
